Could a single drug reduce brain and organ damage after cardiac arrest?
NCT ID NCT07468292
First seen Mar 14, 2026 · Last updated May 22, 2026 · Updated 6 times
Summary
This study tests whether a drug called GC7 can reduce harmful oxidative stress in 20 adults who have been resuscitated after a cardiac arrest. The drug aims to protect cells from damage caused when blood flow returns to the heart and brain. Researchers will measure blood markers of stress, acidity, and inflammation to see if GC7 offers any benefit.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIAC ARREST (CA) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU de Nice - Hôpital PASTEUR 2
Nice, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.